Production (Stage)
STAAR Surgical Company
STAA
$18.68
-$0.09-0.48%
NASDAQ
| 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 42.59M | 48.95M | 88.59M | 99.01M | 77.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.59M | 48.95M | 88.59M | 99.01M | 77.36M |
| Cost of Revenue | 14.58M | 17.30M | 20.10M | 20.59M | 16.32M |
| Gross Profit | 28.01M | 31.65M | 68.49M | 78.41M | 61.04M |
| SG&A Expenses | 49.02M | 47.45M | 48.24M | 52.39M | 49.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 77.27M | 76.80M | 82.84M | 87.04M | 79.57M |
| Operating Income | -34.68M | -27.85M | 5.75M | 11.96M | -2.22M |
| Income Before Tax | -54.49M | -30.33M | 13.16M | 10.33M | -2.21M |
| Income Tax Expenses | -275.00K | 3.89M | 3.18M | 2.96M | 1.13M |
| Earnings from Continuing Operations | -54.21M | -34.23M | 9.98M | 7.38M | -3.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.21M | -34.23M | 9.98M | 7.38M | -3.34M |
| EBIT | -34.68M | -27.85M | 5.75M | 11.96M | -2.22M |
| EBITDA | -32.34M | -25.47M | 7.51M | 13.49M | -979.00K |
| EPS Basic | -1.10 | -0.69 | 0.20 | 0.15 | -0.07 |
| Normalized Basic EPS | -0.40 | -0.38 | 0.17 | 0.13 | -0.03 |
| EPS Diluted | -1.10 | -0.69 | 0.20 | 0.15 | -0.07 |
| Normalized Diluted EPS | -0.40 | -0.38 | 0.17 | 0.13 | -0.03 |
| Average Basic Shares Outstanding | 49.34M | 49.27M | 49.20M | 49.13M | 48.91M |
| Average Diluted Shares Outstanding | 49.34M | 49.27M | 49.73M | 49.81M | 48.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |